Medaffcon Makes Medtech Measurable When Data Determines Market Access
Medaffcon brings to the health technology market the kind of effectiveness and cost-conscious thinking well established in the pharmaceutical industry.
Medaffcon expands its network of companies to Omicron ApS and Value Coaching Oy to extend the services available to pharmaceutical and MedTech companies.
Omicron is a Danish company specialized in biostatistics, statistical programming, and real-world evidence (RWE). The combined expertise of Omicron and Medaffcon represents the fields of RWE and data sciences. This collaboration provides the means to conduct real-world studies in an agile and tailored way across Finland and Denmark.
Value Coaching offers services in leadership consulting, coaching, and innovative workshops with strong experience in the pharmaceutical and MedTech industries. Collaboration with Value Coaching strengthens Medaffcon’s network’s service offering and enables conducting joint projects with broad scope and range of expertise.
These collaborations complement Medaffcon’s partner network and further strengthen our capabilities to provide Nordic-wide services.
Jarmo Hahl
Managing Director
tel: +358 40 139 4001
jarmo.hahl@medaffcon.com
Medaffcon Oy
Medaffcon brings to the health technology market the kind of effectiveness and cost-conscious thinking well established in the pharmaceutical industry.
The objective is to improve access to health data for research and innovation, but the proposal raises concerns about increased administrative burden and the role of industry within the model.
Transportability and generalizability refer to the ability to apply evidence from a single study to different patient populations, clinical settings, or geographical regions.